Institutional shares held 25,978
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership 0.24%
# of Institutions 4


Latest Institutional Activity in HSKA

Top Purchases

Q2 2023
Everence Capital Management Inc Shares Held: 1.95K ($0)
Q2 2023
Ronald Blue Trust, Inc. Shares Held: 7 ($0)
Q1 2023
Fred Alger Management, LLC Shares Held: 829K ($0)
Q1 2023
Bank Of New York Mellon Corp Shares Held: 90.2K ($0)
Q1 2023
Jennison Associates LLC Shares Held: 83.5K ($0)

Top Sells

Q2 2023
Norges Bank Shares Held: 0 ($0)
Q2 2023
Manufacturers Life Insurance Company, The Shares Held: 0 ($0)
Q1 2023
Federated Hermes, Inc. Shares Held: 102K ($0)
Q1 2023
Millennium Management LLC Shares Held: 73.6K ($0)
Q1 2023
Assenagon Asset Management S.A. Shares Held: 49.2K ($0)

About HSKA

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.


Insider Transactions at HSKA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on HSKA

Follow HESKA CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HSKA shares.

Notify only if

Insider Trading

Get notified when an Heska Corp insider buys or sells HSKA shares.

Notify only if

News

Receive news related to HESKA CORP

Track Activities on HSKA